Screener
Immix Biopharma, Inc. IMMX Preferred Stock, Shares Authorized
Preferred Stock, Shares Authorized at other companies
Other financials
Where this comes from
Reported directly by Immix Biopharma, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PreferredStockSharesAuthorized.
The source filing: Immix Biopharma, Inc.’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 5:17 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001493152-26-021764
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Total liabilities | 11,452,001 | 11,044,171 |
| Commitments and contingencies | - | - |
| Stockholders’ equity: | ||
| Preferred stock, $0.0001 par value; 10,000,000 shares authorized; no shares issued and outstanding | - | |
| Common stock, $0.0001 par value; 200,000,000 shares authorized; 53,084,455 shares issued and 53,012,092 shares outstanding at March 31, 2026 and 53,023,466 shares issued and 52,951,103 shares outstanding at December 31, 2025 | 5,307 | 5,301 |
| Additional paid-in capital | 198,903,047 | 198,293,956 |
| Accumulated other comprehensive income | 105,636 | 60,160 |
| Accumulated deficit | (114,549,971) | (104,463,284) |
Document
FAQ
- What is Immix Biopharma, Inc.'s preferred stock, shares authorized?
- Immix Biopharma, Inc. (IMMX) reported preferred stock, shares authorized of $10M in Q1 2026.
- How has Immix Biopharma, Inc.'s preferred stock, shares authorized changed year-over-year?
- Immix Biopharma, Inc.'s preferred stock, shares authorized decreased by 0.0% year-over-year, from $10M to $10M.
Ask your AI about Immix Biopharma, Inc.'s preferred stock, shares authorized.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude